Guizhou Bailing Group Pharmaceutical Co., Ltd. (002424.SZ)
CNY 3.87
(0.0%)
CNY 3.87
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 4.26 Billion | 3.54 Billion | 3.11 Billion | 3.08 Billion | 2.85 Billion | 3.13 Billion |
| Cost of Revenue | 1.95 Billion | 1.41 Billion | 1.25 Billion | 1.34 Billion | 1.13 Billion | 1.26 Billion |
| Gross Profit | 2.31 Billion | 2.12 Billion | 1.85 Billion | 1.74 Billion | 1.71 Billion | 1.87 Billion |
| Operating Expenses | 2.84 Billion | 1.8 Billion | 1.54 Billion | 1.4 Billion | 1.2 Billion | 1.15 Billion |
| Selling, General and Administrative Expenses | 2.39 Billion | 1.6 Billion | 1.34 Billion | 1.21 Billion | 1.03 Billion | 979.41 Million |
| Research and Development Expenses | 42.04 Million | 22.4 Million | 30.42 Million | 36.99 Million | 24.79 Million | 30.84 Million |
| Other Expenses | 120.82 Million | 173.12 Million | 164.12 Million | 156.22 Million | 148.6 Million | 1.57 Million |
| Cost and Expenses | 4.74 Billion | 3.21 Billion | 2.79 Billion | 2.75 Billion | 2.34 Billion | 2.41 Billion |
| Operating Income | -484.41 Million | 357.96 Million | 277.9 Million | 418.79 Million | 493.25 Million | 664.25 Million |
| Interest Expense | 86.84 Million | 101.65 Million | 113.81 Million | 131.3 Million | 111.15 Million | 48.53 Million |
| Income Tax Expense | -80.6 Million | 23.08 Million | 31.06 Million | 55.04 Million | 71.19 Million | 94.05 Million |
| Earnings before Tax | -493.06 Million | 159.05 Million | 147.75 Million | 208.77 Million | 355.74 Million | 665.82 Million |
| Net Income | -414.51 Million | 138.47 Million | 118.48 Million | 152.37 Million | 282.74 Million | 563.23 Million |
| Earnings Per Share Basic | -0.30 | 0.10 | 0.08 | 0.11 | 0.20 | 0.40 |
| Earnings Per Share Diluted | -0.30 | 0.10 | 0.08 | 0.11 | 0.20 | 0.39 |
| Weighted Average Shares Outstanding | 1.38 Billion | 1.39 Billion | 1.39 Billion | 1.41 Billion | 1.41 Billion | 1.4 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.38 Billion | 1.39 Billion | 1.39 Billion | 1.41 Billion | 1.41 Billion | 1.44 Billion |
| Gross Margin | 0.54 | 0.60 | 0.60 | 0.56 | 0.60 | 0.60 |
| EBIT Margin | -0.07 | 0.13 | 0.12 | 0.17 | 0.20 | 0.27 |
| Profit Margin | -0.10 | 0.04 | 0.04 | 0.05 | 0.10 | 0.18 |
| EBITDA | -298.6 Million | 370.04 Million | 353.4 Million | 412.69 Million | 548.39 Million | 757.86 Million |
| Earnings Before Tax Margin | -0.11 | 0.10 | 0.09 | 0.14 | 0.17 | 0.21 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 632.57 Million | 797.03 Million | 1.33 Billion | 1.45 Billion | 4.26 Billion | 910.2 Million |
| Cost of Revenue | 319.08 Million | 358.49 Million | 481.91 Million | 673.51 Million | 1.9 Billion | 408.56 Million |
| Gross Profit | 313.48 Million | 438.53 Million | 850.83 Million | 779.72 Million | 2.35 Billion | 501.63 Million |
| Operating Expenses | 287.11 Million | 366.29 Million | 729.58 Million | 1.29 Billion | 2.61 Billion | 484.35 Million |
| Selling, General and Administrative Expenses | 580.74 Million | 355.32 Million | 714.63 Million | 1.09 Billion | - | 579.43 Million |
| Research and Development Expenses | 2.86 Million | 10.96 Million | 3.02 Million | 18.71 Million | - | 1.04 Million |
| Other Expenses | -296.49 Million | -16.55 Million | -143.28 Thousand | -15.38 Million | -14.51 Million | 970.83 Thousand |
| Cost and Expenses | 606.2 Million | 724.78 Million | 1.21 Billion | 1.96 Billion | 4.52 Billion | 892.92 Million |
| Operating Income | -5.44 Million | 72.24 Million | 64.8 Million | -653.05 Million | -484.41 Million | 27.87 Million |
| Interest Expense | 61.55 Million | - | - | 24.37 Million | 86.84 Million | 17.32 Million |
| Income Tax Expense | -11.39 Million | 64.53 Million | 13.59 Million | -109.23 Million | -80.6 Million | 9.76 Million |
| Earnings before Tax | -8.48 Million | 97.65 Million | 64.66 Million | -662.57 Million | -493.06 Million | 28.84 Million |
| Net Income | 754.62 Thousand | 35.76 Million | 51.69 Million | -554.99 Million | -414.51 Million | 20.14 Million |
| Earnings Per Share Basic | 0.00 | 0.03 | 0.04 | -0.42 | - | 0.01 |
| Earnings Per Share Diluted | 0.00 | 0.03 | 0.04 | -0.42 | - | 0.01 |
| Weighted Average Shares Outstanding | 1.36 Billion | 1.36 Billion | 1.29 Billion | 1.31 Billion | 1.38 Billion | 1.38 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.36 Billion | 1.36 Billion | 1.29 Billion | 1.31 Billion | 1.38 Billion | 1.38 Billion |
| Gross Margin | 0.50 | 0.55 | 0.64 | 0.54 | 0.55 | 0.55 |
| EBIT Margin | 0.08 | 0.13 | 0.11 | -0.36 | - | 0.02 |
| Profit Margin | 0.00 | 0.04 | 0.04 | -0.38 | -0.10 | 0.02 |
| EBITDA | 53.07 Million | 103.62 Million | 150.74 Million | -524.68 Million | - | 17.78 Million |
| Earnings Before Tax Margin | -0.01 | 0.09 | 0.05 | -0.45 | -0.11 | 0.03 |
RAJRATAN
SABSW
SANCO
REYN
TGLO
HCH